25. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci

Hussam Al-Kateb; Thomas Adams; Deborah Fuchs; Patricia K Shadoan; Laurel Johnstone; Branden M Lau; Lee McGhan; Faiz Anwer

首页> 外文期刊>Cancer genetics >25. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci

【24h】

25. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci

机译：25.具有高级B细胞淋巴瘤的患者意外的有利结果，具有Myc，Bcl6和Bcl2基因座异常

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer genetics》 |2018年第2018期|共1页
作者
Hussam Al-Kateb; Thomas Adams; Deborah Fuchs; Patricia K Shadoan; Laurel Johnstone; Branden M Lau; Lee McGhan; Faiz Anwer;
展开▼
作者单位

University of Arizona Banner University Medical Center;

University of Arizona Banner University Medical Center;

University of Arizona Banner University Medical Center;

Cytogenetic laboratory at Banner University Medical Center;

University of Arizona Genetic Core for Clinical Services Laboratory;

University of Arizona Genetic Core for Clinical Services Laboratory;

University of Arizona Banner University Medical Center;

University of Arizona Banner University Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-20 17:03:06

相似文献

外文文献
中文文献
专利

1. A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma [J] . Peng Liu, Sheng Yang, Ting-Yu Wen, 中华医学杂志（英文版） . 2019,第015期
2. Non-anthracycline chemotherapy associated with a poor outcome in elderly Egyptian patients with diffuse large B-cell non-Hodgkin lymphoma [J] . Ahmed A.Zeeneldin, Yasser A.Sallam, Ayman A.Gaber, 癌症转移与治疗（英文版） . 2015,第002期
3. 25. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci [J] . Hussam Al-Kateb, Thomas Adams, Deborah Fuchs, Cancer genetics . 2018,第期

机译：25.具有高级B细胞淋巴瘤的患者意外的有利结果，具有Myc，Bcl6和Bcl2基因座的异常
4. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci [J] . Thomas Adams, Deborah Fuchs, Patricia K Shadoan, Cancer genetics . 2018,第期

机译：具有高级B细胞淋巴瘤的患者意外有利的结果，具有Myc，Bcl6和Bcl2基因群的异常
5. Clinical Significance of BCL2 , C- MYC , and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients [J] . Choo-Yuen Ting, Kian-Meng Chang, Jew-Win Kuan, International Journal of Medical Sciences . 2019,第4期

机译：BCL2，C-MYC和BCL6遗传异常，爱泼斯坦-巴尔病毒感染，CD5蛋白表达，生发中心B细胞/非生发中心B细胞亚型，MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达：120例患者的临床和病理相关性研究
6. Predicting MYC translocation in HE specimens of diffuse large B-cell lymphoma through deep learning [C] . Zaneta Swiderska-Chadaj, Konnie Hebeda, Michiel van den Brand, Conference on Medical Imaging: Digital Pathology . 2020

机译：通过深度学习预测弥漫性大B细胞淋巴瘤标本的MYC易位
7. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
8. Clinical Significance of BCL2 C-MYC and BCL6 Genetic Abnormalities Epstein-Barr Virus Infection CD5 Protein Expression Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients [O] . Choo-Yuen Ting, Kian-Meng Chang, Jew-Win Kuan, 2019

机译：BCL2C-MYC和BCL6遗传异常爱泼斯坦-巴尔病毒感染CD5蛋白表达生发中心B细胞/非生发中心B细胞亚型MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达：120例患者的临床和病理相关性研究
9. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology [O] . David W. Scott, Rebecca L. King, Annette M. Staiger, 2018

机译：高级B细胞淋巴瘤，具有Myc和Bcl2和/或Bcl6重排，弥漫性大B细胞淋巴瘤形态

25. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci

著录项

相似文献

相关主题

期刊订阅